Navigation Links
New survey highlights growing concern about risk of infection in cancer patients
Date:5/28/2009

THOUSAND OAKS, Calif., May 27, 2009 Amgen (NASDAQ: AMGN) today announced the results of a national Harris Interactive, Inc. survey indicating that the vast majority of oncologists and infectious disease (ID) specialists are highly concerned about the negative impact infection may have on treatment outcomes in chemotherapy patients, as well as emerging antibiotic resistance. Nearly all oncologists surveyed (92 percent) believe it is important for cancer patients to prevent infections to achieve successful treatment outcomes. Antibiotic resistance is a growing concern among the majority of physicians surveyed, with 96 percent of ID specialists and 79 percent of oncologists reporting an increase in antibiotic-resistant infections in cancer patients over the past five years. Both groups of physicians report methicillin-resistant Staphylococcus aureus (MRSA) infections as the most commonly observed in chemotherapy patients.

Cancer patients are at a higher risk for infection due to a compromised immune system caused by both the cancer and chemotherapy treatment. Neutropenia, a low white blood cell count, is a common and potentially dangerous side effect in patients receiving strong chemotherapy. It can lead to a heightened risk of infection that can require hospitalization and be life-threatening. Each year, 60,000 cancer patients are hospitalized for chemotherapy-induced neutropenia, and a patient dies every two hours from this complication. Neutropenia also can potentially disrupt chemotherapy treatment, including both dose delays and dose reductions. Studies show that for certain types of cancer, chemotherapy produces the best long-term results when patients receive the full dose on schedule.

"The survey findings show that one in four chemotherapy patients report having an infection during treatment, with more than a third requiring a second course of antibiotics," said Sean Harper, M.D., chief medical officer and head of Global Development at A
'/>"/>

Contact: Ashleigh Koss
805-313-6151
Amgen, Inc.
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Survey reveals disparities in skin cancer knowledge, protection among high school students
2. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
3. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
4. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
5. Youth Drug Use at a Five Year Low, New Survey Shows
6. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
7. Parental surveys boost diagnosis abilities of pediatricians
8. National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline
9. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
10. PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care
11. Launch of second European Cancer Research Funding survey

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...identify those who would benefit from liver surger..., Dec. 1 (HealthDay News) -- A CT scan of liver tu... help predict overall survival after chemotherapy,...tin) to cytotoxic chemotherapy has been shown to i...ctal cancer and to produce better results in patie...
(Date:12/1/2009)... Practitioners of any medical, ...ption are breathing a sigh of relief this week wit.... The application, released over the holiday week...ibe voice recordings to do so quickly and seamless... (PRWEB) December 1, 2009 -- The iPhon...
(Date:12/1/2009)... , ,, NEW YORK, Dec. 1 /PRNews... global leader in the development and delivery of ...he medical, scientific and academic markets, will ...l Search, our first-to-market cross-platform searc...logy lexicon, based on the American Psychological ...
(Date:12/1/2009)... , FORT LAUDERDALE, Fla., Dec. 1 /PRNewswire/...atient enrollment in the randomized clinical trial...nt (Combo Stent). ,, A prospective, randomized,...aluation of an ablu M inal sirolimus coat ED ...ents at up to 20 sites in Asia, Australia, Europe ...
(Date:12/1/2009)...real, December 1, 2009 A Universit de Montral res...Center on Family Violence and Violence Against Wom...s of pornography on men. "We started our research ...ed pornography. We couldn,t find any," says Simon ...ssor at the School of Social Work. , "The objec...
Breaking Medicine News(10 mins):Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Are the effects of pornography negligible? 2
...in automated,medication management, today unveiled...t remote dispensing system designed exclusively fo...eir care. , The company made the announcemen...stem are operating in Texas, and each,InSite unit ...
...tional, Inc. (Amex: BUF ), announced today the C...scuss current business conditions on Tuesday,Novem... number is,(866) 901-2585. The international call ... ctrego@minrad.com , (716) 85...
...e for anti-aging drug trials, study says , ...biomarkers that are highly accurate in determining...hers at California,s Buck Institute for Age Resear... changes in gene expression, and complex computer ...
...., the makers of,Carmex(R) lip balms, today unveil... association with the new site,s launch, the compa...rmex.com. , "We know that Carmex users are s...flects this lifestyle and enables our,customers to...
...ce advertising,agency, recently received two prest...dia (MM&M), a leading healthcare publication. ... and effectiveness in healthcare marketing. Mango...m/cgi-bin/prnh/20081119/AQW573 ) , (Logo: ...
... Larry King,turns 75. In conjunction with his birt...alth Solutions and the LAC+USC Camino de Salud Net...ala in Los Angeles. The,Foundation, which provides...to quintuple-bypass surgery. He decided then, he w...
Other Medicine News:Health News:Talyst Unveils InSite for Long-Term Care 2Health News:Talyst Unveils InSite for Long-Term Care 3Health News:Researchers ID Suite of Genes in Aging Process 2Health News:Carma Laboratories Launches New Carmex(R) Web Site; Unveils Top 10 Reasons for a Virtual Visit 2Health News:Mangos Wins Two Gold Awards 2Health News:The King of Hearts Helps Others Follow a Healthy Road 2Health News:The King of Hearts Helps Others Follow a Healthy Road 3Health News:The King of Hearts Helps Others Follow a Healthy Road 4
(Date:12/1/2009)..., , GLEN BURNIE, Md., Dec. 1 ...agnostic service provider for home testing and eva...nced it has named Richard Hassett, M.D., as its ch...president of Matria Healthcare, during its growth ...o a $350 million industry leader in total populati...
(Date:12/1/2009)..., , CHICAGO, Dec. 1 At t...ety of North America (RSNA), Royal Philips Electro...Breast Workspace, a set of solutions that provides... breast images at one workspot to help drive quali...reast care, Philips will also highlight new capabi...
(Date:12/1/2009)..., , ALBUQUERQUE, N.M., Dec. 1 /PRNewswire/ -...s laboratory that discovers, develops and markets ...ointment of Scott Glenn as chairman of the company... ,, Prior to joining Exagen, Glenn was managing... of a number of successful biomedical companies in...
Breaking Medicine Technology:Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Too Few Americans Get HIV Test Early Enough 50100 1Too Few Americans Get HIV Test Early Enough 50100 2Too Few Americans Get HIV Test Early Enough 50100 3New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 1New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 2Your arteries on Wonder bread 50090 1Your arteries on Wonder bread 50090 2
...gh-Risk Infants Versus,Current Standard of Care an... RSV- Related Lower Respiratory Infections -, TORO...une, Inc.,today announced positive results from a ...f respiratory syncytial virus (RSV). The,trial com...antibody,(MAb) also known as Numax(R), with Synagi...
...Occurs at the 55th Annual,Clinical Meeting of the ...s, COLLEGEVILLE, Pa., May 09, 2007 /PRNewswire-Fir...eth , presented results from the,first Phase 3 stu...he treatment of moderate-to-severe vasomotor sympt... menopause. These studies showed,that women who to...
Other Medicine Technology:MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 2MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 3MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 4MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 5MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 6MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 7Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 2Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 3Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 4Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 5Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 6
LICOX Brain Tissue Oxygen Monitoring System
Hough Hough Burr-Saw for Crurotomy
...iva Parkinson's Control Therapy uses electrical st...the most disabling motor symptoms of Parkinson's d...fe and effective adjunctive treatment option for m...rigidity, bradykinesia/akinesia and/or tremor whi...
...features over 600 TV lines of resolution with RGB,...emperature selections, scanning size selection and...l allows the user to easily set up and operate the...ness, chroma, phase, contrast, volume and aperture...
Medicine Products: